Scheffler, Armin
Wenzel, Pauline
Bendig, Merle
Gendolla, Astrid
Basten, Jale
Kleinschnitz, Christoph
Nsaka, Michael
Lindner, Diana
Naegel, Steffen
Burow, Philipp
Fleischmann, Robert
Holle, Dagny
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 12 April 2024
Accepted: 9 May 2024
First Online: 16 May 2024
Declarations
:
: The analysis was approved by the independent ethics committee of the University Hospital Essen (19–9004-BO). Because of retrospective analysis of internal routine data, no special written informed consent was necessary for this specific analysis.
: Not applicable.
: PB received honoraria for speaking engagements from Novartis, Eli Lilly, Teva, Allergan Pharma/AbbVie and Lundbeck, for advisory boards from Teva and received scientific support from Novartis.DH has received scientific support and/or honoraria from Biogen, Novartis, Eli Lilly, Sanofi-Aventis, Teva, Allergan, Hormosan.RF received honoraria and travel fees, a consulting or advisory role to declare from Teva, Eli Lilly, Allergan Pharma/AbbVie, Ipsen, Lundbeck and Novartis.AG has received non-financial support and personal fees for talks and adboards, non-personal support for participation in clinical trials from Allergan, Eli Lilly, Hormosan, Teva Pharmaceutical, Grunenthal, Mundipharma, Esanum, DGS. AG reports personal fees from Eli Lilly, Novartis and Teva Pharmaceutical.CK has received honoraria, a consulting or advisory role to declare from Novartis and Teva.MN received travel fees from Licher MT.SN received financial support for consulting and speaking engagements from Allergan, Hormosan, Lilly, Lundbeck, Novartis and Teva.AS has received travel fees from Teva and honoraria from Novartis (advisory board).JB, MB, PW declare that there is no conflict of interest.